The ANKRD18B Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout cell population designed to ablate ANKRD18B protein expression. This heterogeneous pool of genetically modified human cells, derived from the HEK293T line, enables researchers to study the consequences of ANKRD18B loss without the constraints of clonal selection. The polyclonal format offers a robust, population-level model for loss-of-function experiments.
The parental HEK293T cell line originates from human embryonic kidney cells immortalized through constitutive expression of adenovirus 5 E1A/E1B gene products and SV40 large T antigen. These genetic features confer high transfection efficiency and support robust transient and stable protein production, making HEK293T a workhorse for recombinant protein expression, viral vector packaging, and functional genomics. Its well-characterized biology ensures experimental reproducibility across a wide range of molecular and cellular assays.
ANKRD18B is an uncharacterized member of the ankyrin repeat domain-containing protein family. Ankyrin repeats, typically present in tandem arrays, are one of the most common protein-protein interaction motifs and often function as scaffolds to assemble signaling complexes. Consistent with this, ANKRD18B is predicted to act as a scaffold or adaptor protein, potentially mediating the formation of multiprotein networks. To date, however, no specific interacting partners, upstream regulators, or downstream effectors have been identified. The mechanistic summary posits that ANKRD18B participates in protein-protein interaction networks via its ankyrin repeats, and its knockout is anticipated to disrupt these uncharacterized interactions, offering an entry point for discovery.
When introduced into HEK293T cells, the ANKRD18B knockout model leverages the host’s experimental tractability to probe the gene’s still-undefined biological function. The HEK293T background permits high-efficiency delivery of exogenous constructs, enabling complementation experiments to validate phenotypes. Because ANKRD18B has no established role in canonical pathways, this polyclonal knockout population is particularly suited for unbiased phenotypic screens and interaction proteomics to uncover its molecular context. Comparison of wild-type and knockout cells can reveal alterations in cell proliferation, migration, and global protein interaction landscapes.
Key research applications encompass functional characterization of ANKRD18B, exploration of ankyrin repeat domain biology, and early-stage target validation in drug discovery. Recommended orthogonal assays include western blotting and RT-qPCR for knockout confirmation and transcriptional analysis; co-immunoprecipitation and mass spectrometry-based interactomics to map protein networks; and functional assays such as cell proliferation and migration analyses to assess phenotypic impact. This polyclonal knockout resource accelerates investigation of a poorly annotated gene. For technical inquiries, contact Ascent Research.
